Summary
Uses Centers for Disease Control and Prevention (CDC) WONDER (International Classification of Diseases, 10th revision [ICD-10], 1999–2010) to decompose racial/ethnic mortality disparities by cause of death for four minority groups vs. non-Hispanic whites, measuring both relative (age-adjusted mortality ratio, AAMR) and absolute (difference in years of life lost, dYLL) dimensions across the 25 leading ICD-10 subchapter causes. Black-white disparities are the largest in absolute terms, led by assault (4.5M excess YLL) and cancer (3.8M excess YLL). Hispanic and Asian/Pacific Islander (API) populations have overall mortality advantages relative to whites ("Hispanic paradox"; API advantage). American Indian/Alaska Native (AIAN) have moderate absolute disparities driven by assault, liver disease, and diabetes.
Key Claims
Black–White Disparities (largest absolute burden)
- Assault (homicide): AAMR 7.56 — largest relative disparity; dYLL 4.5 million — largest absolute disparity. Driven primarily by socioeconomic and psychosocial factors.
- Malignant neoplasms: dYLL 3.8 million — second largest absolute contributor; AAMR 1.37.
- Cardiovascular diseases: Hypertensive diseases AAMR 2.99; ischemic heart disease (IHD) AAMR 1.22; renal failure AAMR 2.35. All contribute substantially to absolute YLL gaps.
- Blacks have lower risk for some causes: suicide/intentional self-harm (AAMR 0.41; dYLL −1.2 million — the largest "favorable" disparity); also extrapyramidal disorders and organic mental disorders.
Hispanic–White Disparities (modest; "Hispanic paradox")
- Only three causes contributed substantially to Hispanic disadvantage: assault (AAMR ~1.7), diabetes, and liver diseases.
- Hispanics have lower mortality than whites for most major causes (cancer, heart disease, chronic obstructive pulmonary disease [COPD]), producing the overall Hispanic mortality paradox — lower mortality despite lower average socioeconomic status (SES).
AIAN–White Disparities (moderate; multiple causes)
- Largest contributors: assault (AAMR 3.25; dYLL 98,000), liver diseases (AAMR 3.06; dYLL 218,000), diabetes (AAMR 2.37; dYLL 118,000), transport accidents (AAMR 2.10; dYLL 248,000).
- AIAN had lower risk for the five leading causes (malignant neoplasms AAMR 0.80; IHD AAMR 0.84; COPD AAMR 0.82).
API–White Disparities (API advantage)
- API had no cause of death with higher risk or higher YLL than whites.
- Largest API advantages: malignant neoplasms (AAMR 0.60; dYLL −2.0 million) and ischemic heart disease (AAMR 0.57; dYLL −1.4 million).
Methodological Notes
- The relative and absolute measures tell different stories: high AAMR with low dYLL (e.g., assault for AIAN) indicates large relative risk on a low-prevalence cause; focusing only on AAMR inflates perceived importance of rare causes.
- Death certificate race/ethnicity misclassification (numerator from certificates; denominator from Census self-report) is acknowledged as a key limitation — cites Arias et al. (2008); minimal concern for black-white comparisons but larger for AIAN and Hispanics.
Concepts Introduced or Extended
Entities Mentioned
Quotes
"Many causes contributed to disparities between non-Hispanic whites and blacks, led by assault (AAMR, 7.56; dYLL, 4.5 million)."
"Only assault, diabetes, and diseases of the liver contributed substantially to disparities between non-Hispanic whites and Hispanics."
My Take
A useful cause-of-death decomposition that complements Meseguer (2024) — which tracks trend data 1999–2019 — by providing the cross-sectional disease-specific contributions at the beginning of that window. The paper's key methodological point (that relative and absolute measures produce different rankings) is important when assigning policy priorities: assault is the most striking relative disparity for blacks and AIAN, but cancer and cardiovascular disease account for far more absolute YLL. For the wiki's DI literature, the most relevant finding is that cardiovascular, renal, and hypertensive disease drive a substantial share of the black-white mortality gap — conditions closely linked to the disability and chronic disease burden that underlies disability insurance (DI) and Supplemental Security Income (SSI) enrollment patterns.